Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $82,375 | 48 | 86.1% |
| Food and Beverage | $7,442 | 187 | 7.8% |
| Consulting Fee | $4,886 | 7 | 5.1% |
| Travel and Lodging | $730.05 | 3 | 0.8% |
| Honoraria | $175.00 | 1 | 0.2% |
| Education | $69.28 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $82,355 | 106 | $0 (2024) |
| Amgen Inc. | $10,502 | 25 | $0 (2024) |
| GENZYME CORPORATION | $1,059 | 29 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $282.25 | 12 | $0 (2024) |
| Aimmune Therapeutics, Inc. | $175.00 | 1 | $0 (2022) |
| Genentech USA, Inc. | $172.95 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $154.64 | 28 | $0 (2021) |
| CSL Behring | $143.50 | 5 | $0 (2024) |
| ADMA BioManufacturing LLC | $142.49 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $138.34 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46,827 | 84 | AstraZeneca Pharmaceuticals LP ($45,939) |
| 2023 | $27,651 | 57 | AstraZeneca Pharmaceuticals LP ($21,063) |
| 2022 | $19,601 | 40 | AstraZeneca Pharmaceuticals LP ($15,254) |
| 2021 | $788.43 | 8 | GENZYME CORPORATION ($659.87) |
| 2020 | $64.07 | 3 | Optinose US, Inc. ($34.99) |
| 2019 | $312.92 | 14 | Regeneron Healthcare Solutions, Inc. ($174.40) |
| 2018 | $162.90 | 11 | AstraZeneca Pharmaceuticals LP ($39.17) |
| 2017 | $268.76 | 34 | Teva Pharmaceuticals USA, Inc. ($130.13) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Inflammation & Immunology | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $151.03 | General |
| Category: Immunology | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $104.06 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Inflammation & Immunology | ||||||
| 10/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $31.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Immunology | ||||||
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $29.82 | General |
| Category: Oncology / Rare Diseases | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 567 | 4,562 | $106,089 | $47,687 |
| 2022 | 9 | 379 | 4,001 | $86,616 | $39,263 |
| 2021 | 10 | 452 | 5,000 | $102,084 | $45,595 |
| 2020 | 11 | 375 | 3,586 | $78,503 | $31,529 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 168 | $25,200 | $14,415 | 57.2% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 78 | 995 | $17,910 | $10,287 | 57.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 111 | 751 | $19,526 | $5,982 | 30.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 42 | 1,981 | $17,829 | $5,522 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $8,160 | $3,787 | 46.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $4,350 | $2,043 | 47.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 28 | 298 | $3,278 | $1,727 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 27 | $2,700 | $1,434 | 53.1% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 39 | 212 | $4,240 | $1,433 | 33.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 47 | 53 | $2,756 | $1,032 | 37.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 14 | 14 | $140.00 | $25.22 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 142 | $21,300 | $12,140 | 57.0% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 44 | 2,321 | $20,889 | $6,655 | 31.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 29 | 584 | $10,512 | $6,030 | 57.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 32 | 470 | $12,220 | $3,600 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $6,000 | $3,249 | 54.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $5,760 | $2,631 | 45.7% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 35 | 329 | $3,619 | $2,030 | 56.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 33 | $3,300 | $1,819 | 55.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 53 | 58 | $3,016 | $1,109 | 36.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 158 | $23,700 | $13,456 | 56.8% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 60 | 3,103 | $27,927 | $9,260 | 33.2% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 43 | 589 | $10,602 | $5,956 | 56.2% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 40 | 503 | $13,078 | $3,847 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 54 | $5,400 | $3,506 | 64.9% |
About Charles Debrosse
Charles Debrosse is a Pediatrics healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1700043155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Charles Debrosse has received a total of $95,676 in payments from pharmaceutical and medical device companies, with $46,827 received in 2024. These payments were reported across 251 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($82,375).
As a Medicare-enrolled provider, Debrosse has provided services to 1,773 Medicare beneficiaries, totaling 17,149 services with total Medicare billing of $164,074. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Location Cincinnati, OH
- Active Since 05/21/2008
- Last Updated 12/29/2016
- Taxonomy Code 208000000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700043155
Products in Payments
- TEZSPIRE (Biological) $53,962
- AIRSUPRA (Drug) $27,842
- FASENRA (Biological) $8,119
- DUPIXENT (Biological) $1,288
- PALFORZIA (Biological) $175.00
- Xolair (Biological) $172.95
- Hizentra (Biological) $143.50
- BREZTRI (Drug) $116.75
- XOLAIR (Biological) $96.28
- NUCALA (Biological) $90.97
- QVAR (Drug) $72.78
- CINQAIR (Drug) $56.21
- CIBINQO (Drug) $50.61
- SYMBICORT (Drug) $45.29
- DUPIXENT (Drug) $42.59
- XOLAIR (Drug) $38.05
- Auvi-Q (Drug) $37.87
- CINRYZE (Drug) $37.65
- Xhance (Drug) $34.99
- Ryaltris (Drug) $31.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Cincinnati
Ashish Kumar, Md, MD
Pediatrics — Payments: $349,627
Andrew Dauber, M.d, M.D
Pediatrics — Payments: $179,732
Nana-Hawa Yayah Jones, Md, MD
Pediatrics — Payments: $87,676
Jae Kim, M.d, M.D
Pediatrics — Payments: $73,122
Cuixia Tian, M.d, M.D
Pediatrics — Payments: $72,264
Scott Wexelblatt, M.d, M.D
Pediatrics — Payments: $29,285